|
|
(27 intermediate revisions by 3 users not shown) |
Line 4: |
Line 4: |
|
| |
|
| ==Overview== | | ==Overview== |
| Pelvic MRI may be diagnostic of endometrial cancer.
| | The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.<ref name=":0">{{Cite web | title =endometrial cancer MRI | url =http://radiopaedia.org/articles/endometrial-carcinoma}}</ref> |
|
| |
|
| ==Pelvic MRI== | | ==Pelvic MRI== |
| A dedicated pelvic MRI protocol is recommended for optimal assessment.<ref>{{Cite web | title =endometrial cancer MRI | url =http://radiopaedia.org/articles/endometrial-carcinoma}}</ref>
| | The MRI is not needed for the diagnosis of endometrial cancer. However, an MRI may be helpful in staging of the disease.<ref name=":0" /> |
| MRI is considered superior to CT for local staging. Contrast enhanced MRI imaging improves accuracy in detecting myometrial invasion.
| |
| * T1: hypo- to isointense to normal [[endometrium]]
| |
| * T1 C+(Gd): carcinomatous tissue will enhance less than normal endometrium
| |
| * T2: hyperintense or heterogeneous relative to normal endometrium
| |
|
| |
|
| | {| style="border: 0px; font-size: 90%; margin: 3px; width: 600px" align="center" |
| | | valign="top" | |
| | |+ |
| '''MR Imaging findings according to FIGO stage''' | | '''MR Imaging findings according to FIGO stage''' |
| :* stage 1: [[tumour]] confined to [[uterus]] | | ! style="background: #4479BA; width: 200px;" | {{fontcolor|#FFF|Stage of endometrial cancer}} |
| ::* stage 1a: tumour confined to the uterine endometrium
| | ! style="background: #4479BA; width: 400px;" | {{fontcolor|#FFF|MRI findings}} |
| :::* normal or widened endometrium
| | |- |
| :::* normal low T2 signal junctional zone
| | | style="padding: 5px 5px; background: #DCDCDC; font-weight: bold" | |
| :::* complete subendometrial enhancement on T1 contrast imaging
| | Stage 1: tumor confined to uterus |
| ::* stage 1b: invasion of less than half of the myometrium
| | | style="padding: 5px 5px; background: #F5F5F5;" | |
| :::* disruption or irregularity of the low T2 signal junctional zone
| | :1a. |
| :::* disruption of subendometrial early enhancement | |
| ::* stage 1c: invasion of outer half of myometrium
| |
| :::* disruption or irregularity of the low T2 signal junctional zone | |
| :::* disruption of subendometrial early enhancement | |
| :::* preservation of band of outer [[myometrium]]
| |
| :* stage 2: tumour extends to [[cervix]]
| |
| ::* stage 2a
| |
| :::* widening of internal os and endocervical canal by high/isointense T2W signal tumour mass.
| |
| :::* intact low T2W signal of normal cervical stroma
| |
| ::* stage 2b
| |
| :::* widening of internal os and endocervical canal by high/isointense T2W signal tumour mass
| |
| :::* disruption of low T2 signal cervical stroma
| |
| :* stage 3: tumour extension beyond the [[uterus]]
| |
| ::* stage 3a
| |
| :::* irregularity to the uterine contour
| |
| :::* disruption of low T2 signal uterine serosa
| |
| ::* stage 3b
| |
| :::* thickening of vaginal wall
| |
| :::* high T2 signal tumour infiltrating low signal vaginal wall
| |
| ::* stage 3c
| |
| :::* pelvic/para aortic lymph node involvement
| |
| :::* short axis >/= 8 mm in pelvic nodes
| |
| :* stage 4: bladder/rectal or distant metastasis | |
| ::* stage 4a | |
| :::* disruption of low T2 signal [[bladder]] or rectal wall
| |
| :::* intraluminal bladder mass
| |
|
| |
|
| {| style="border: 0px; font-size: 90%; margin: 3px;" align=center
| | :* Disruption or irregularity of the low T2 signal junctional zone |
| |+
| | :* Disruption of subendometrial early enhancement |
| ! style="background: #4479BA; width: 120px;" | {{fontcolor|#FFF|Stage}}
| | :1b. |
| ! style="background: #4479BA; width: 550px;" | {{fontcolor|#FFF|MRI Findings}}
| | :* Disruption or irregularity of the low T2 signal junctional zone |
| |-
| | :* Disruption of subendometrial early enhancement |
| | style="padding: 5px 5px; background: #DCDCDC;" | '''Stage I'''
| | :* Preservation of band of outer myometrium |
| | style="padding: 5px 5px; background: #F5F5F5;" | Tumor confined to the corpus uteri
| |
| |-
| |
| | rowspan=4 style="padding: 5px 5px; background: #DCDCDC;" | '''IA'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | No or less than half myometrial invasion
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| | rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" | '''IB'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Invasion equal to or more than half of the [[myometrium]]|-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" |'''Stage II'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades cervical stroma but does not extend beyond the [[uterus]]
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" | '''Stage III'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Local and/or regional spread of the tumor
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| |style="padding: 5px 5px; background: #DCDCDC;" |'''IIIA'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades the serosa of the corpus uteri and/or adnexae
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" |'''IIIB'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Vaginal involvement and/or parametrial involvement
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |- | | |- |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | |
| | Stage 2: tumor extends to cervix |
| | | style="padding: 5px 5px; background: #F5F5F5;" | |
| | :* Widening of internal os and endocervical canal by high/isointense T2W signal tumor mass. |
| | :* Intact low T2W signal of normal cervical stroma |
| | :* Disruption of low T2 signal cervical stroma |
| |- | | |- |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging | | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | |
| |-
| | Stage 3: tumor extension beyond the uterus |
| | rowspan=3 style="padding: 5px 5px; background: #DCDCDC;" | '''III C'''
| | | style="padding: 5px 5px; background: #F5F5F5;" | |
| | style="padding: 5px 5px; background: #F5F5F5;" | Metastases to pelvic and/or para-aortic lymph nodes
| | :3a |
| |-
| | :* Irregularity to the uterine contour |
| | style="padding: 5px 5px; background: #F5F5F5;" | (i) Positive pelvic nodes | | :* Disruption of low T2 signal uterine serosa |
| |-
| | :3b |
| | style="padding: 5px 5px; background: #F5F5F5;" | (ii) Positive para-aortic nodes with or without positive pelvic [[lymph nodes]]
| | :* Thickening of vaginal wall |
| |-
| | :* High T2 signal tumor infiltrating low signal vaginal wall |
| | style="padding: 5px 5px; background: #DCDCDC;" | '''Stage IV'''
| | :3c |
| | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invades bladder and/or bowel mucosa, and/or distant metastases
| | :* Pelvic/para aortic lymph node involvement |
| |-
| | :* Short axis ≥ 8 mm in pelvic nodes |
| | style="padding: 5px 5px; background: #DCDCDC;" | '''IVA'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Tumor invasion of [[bladder]] and/or bowel mucosa
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |-
| |
| | style="padding: 5px 5px; background: #DCDCDC;" | '''IVB'''
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | Distant metastasis, including intra-abdominal [[metastases]] and/or inguinal nodes
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal or widened endometrium
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | normal low T2 signal junctional zone
| |
| |-
| |
| | style="padding: 5px 5px; background: #F5F5F5;" | complete subendometrial enhancement on T1 contrast imaging
| |
| |- | | |- |
| | | style="padding: 5px 5px; background: #DCDCDC;font-weight: bold" | |
| | Stage 4: bladder/rectal or distant metastasis |
| | | style="padding: 5px 5px; background: #F5F5F5;" | |
| | :4a |
| | :* Disruption of low T2 signal [[bladder]] or rectal wall |
| | :* Intraluminal bladder mass |
| |} | | |} |
|
| |
|
Line 150: |
Line 67: |
| {{WikiDoc Help Menu}} | | {{WikiDoc Help Menu}} |
| {{WikiDoc Sources}} | | {{WikiDoc Sources}} |
| | [[Category:Up-To-Date]] |
| | [[Category:Oncology]] |
| | [[Category:Medicine]] |
| | [[Category:Gynecology]] |
| | [[Category:Surgery]] |